Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Hemostats Market

ID: MRFR/MED/15171-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US Hemostats Market Research Report By Product Type (Thrombin-based Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Cellulose-based Hemostats, Other Hemostatic Agents), By Application (Surgical Procedure, Traumatic Injury, Dental Procedure, Obstetrics and Gynecology, Other Applications), By Formulation (Lyophilized Powder, Liquid, Ready-to-use, Foam, Other Formulations) and By End Use (Hospitals, Ambulatory Surgical Centers, Research Laboratories, Military Institutions) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Hemostats Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Food, Beverages & Nutrition, BY Type (USD Million)
  49.     4.1.1 Thrombin-based Hemostats
  50.     4.1.2 Gelatin-based Hemostats
  51.     4.1.3 Collagen-based Hemostats
  52.     4.1.4 Cellulose-based Hemostats
  53.     4.1.5 Other Hemostatic Agents
  54.   4.2 Food, Beverages & Nutrition, BY Application (USD Million)
  55.     4.2.1 Surgical Procedures
  56.     4.2.2 Traumatic Injuries
  57.     4.2.3 Dental Procedures
  58.     4.2.4 Obstetrics and Gynecology
  59.     4.2.5 Other Applications
  60.   4.3 Food, Beverages & Nutrition, BY Formulation (USD Million)
  61.     4.3.1 Lyophilized Powder
  62.     4.3.2 Liquid
  63.     4.3.3 Ready-to-use
  64.     4.3.4 Foam
  65.     4.3.5 Other Formulations
  66.   4.4 Food, Beverages & Nutrition, BY End Use (USD Million)
  67.     4.4.1 Hospitals
  68.     4.4.2 Ambulatory Surgical Centers
  69.     4.4.3 Research Laboratories
  70.     4.4.4 Military Institutions
  71. 5 SECTION V: COMPETITIVE ANALYSIS
  72.   5.1 Competitive Landscape
  73.     5.1.1 Overview
  74.     5.1.2 Competitive Analysis
  75.     5.1.3 Market share Analysis
  76.     5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  77.     5.1.5 Competitive Benchmarking
  78.     5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  79.     5.1.7 Key developments and growth strategies
  80.       5.1.7.1 New Product Launch/Service Deployment
  81.       5.1.7.2 Merger & Acquisitions
  82.       5.1.7.3 Joint Ventures
  83.     5.1.8 Major Players Financial Matrix
  84.       5.1.8.1 Sales and Operating Income
  85.       5.1.8.2 Major Players R&D Expenditure. 2023
  86.   5.2 Company Profiles
  87.     5.2.1 Johnson & Johnson (US)
  88.       5.2.1.1 Financial Overview
  89.       5.2.1.2 Products Offered
  90.       5.2.1.3 Key Developments
  91.       5.2.1.4 SWOT Analysis
  92.       5.2.1.5 Key Strategies
  93.     5.2.2 Baxter International (US)
  94.       5.2.2.1 Financial Overview
  95.       5.2.2.2 Products Offered
  96.       5.2.2.3 Key Developments
  97.       5.2.2.4 SWOT Analysis
  98.       5.2.2.5 Key Strategies
  99.     5.2.3 Medtronic (US)
  100.       5.2.3.1 Financial Overview
  101.       5.2.3.2 Products Offered
  102.       5.2.3.3 Key Developments
  103.       5.2.3.4 SWOT Analysis
  104.       5.2.3.5 Key Strategies
  105.     5.2.4 Stryker Corporation (US)
  106.       5.2.4.1 Financial Overview
  107.       5.2.4.2 Products Offered
  108.       5.2.4.3 Key Developments
  109.       5.2.4.4 SWOT Analysis
  110.       5.2.4.5 Key Strategies
  111.     5.2.5 Terumo Corporation (JP)
  112.       5.2.5.1 Financial Overview
  113.       5.2.5.2 Products Offered
  114.       5.2.5.3 Key Developments
  115.       5.2.5.4 SWOT Analysis
  116.       5.2.5.5 Key Strategies
  117.     5.2.6 B. Braun Melsungen AG (DE)
  118.       5.2.6.1 Financial Overview
  119.       5.2.6.2 Products Offered
  120.       5.2.6.3 Key Developments
  121.       5.2.6.4 SWOT Analysis
  122.       5.2.6.5 Key Strategies
  123.     5.2.7 Hemostasis, Inc. (US)
  124.       5.2.7.1 Financial Overview
  125.       5.2.7.2 Products Offered
  126.       5.2.7.3 Key Developments
  127.       5.2.7.4 SWOT Analysis
  128.       5.2.7.5 Key Strategies
  129.     5.2.8 Z-Medica, LLC (US)
  130.       5.2.8.1 Financial Overview
  131.       5.2.8.2 Products Offered
  132.       5.2.8.3 Key Developments
  133.       5.2.8.4 SWOT Analysis
  134.       5.2.8.5 Key Strategies
  135.   5.3 Appendix
  136.     5.3.1 References
  137.     5.3.2 Related Reports
  138. 6 LIST OF FIGURES
  139.   6.1 MARKET SYNOPSIS
  140.   6.2 US MARKET ANALYSIS BY TYPE
  141.   6.3 US MARKET ANALYSIS BY APPLICATION
  142.   6.4 US MARKET ANALYSIS BY FORMULATION
  143.   6.5 US MARKET ANALYSIS BY END USE
  144.   6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
  145.   6.7 RESEARCH PROCESS OF MRFR
  146.   6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
  147.   6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  148.   6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  149.   6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
  150.   6.12 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
  151.   6.13 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Million)
  152.   6.14 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 (% SHARE)
  153.   6.15 FOOD, BEVERAGES & NUTRITION, BY APPLICATION, 2024 TO 2035 (USD Million)
  154.   6.16 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 (% SHARE)
  155.   6.17 FOOD, BEVERAGES & NUTRITION, BY FORMULATION, 2024 TO 2035 (USD Million)
  156.   6.18 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 (% SHARE)
  157.   6.19 FOOD, BEVERAGES & NUTRITION, BY END USE, 2024 TO 2035 (USD Million)
  158.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  159. 7 LIST OF TABLES
  160.   7.1 LIST OF ASSUMPTIONS
  161.     7.1.1
  162.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  163.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  164.     7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  165.     7.2.3 BY FORMULATION, 2025-2035 (USD Million)
  166.     7.2.4 BY END USE, 2025-2035 (USD Million)
  167.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  168.     7.3.1
  169.   7.4 ACQUISITION/PARTNERSHIP
  170.     7.4.1

US Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Million, 2025-2035)

  • Thrombin-based Hemostats
  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Cellulose-based Hemostats
  • Other Hemostatic Agents

Food, Beverages & Nutrition By Application (USD Million, 2025-2035)

  • Surgical Procedures
  • Traumatic Injuries
  • Dental Procedures
  • Obstetrics and Gynecology
  • Other Applications

Food, Beverages & Nutrition By Formulation (USD Million, 2025-2035)

  • Lyophilized Powder
  • Liquid
  • Ready-to-use
  • Foam
  • Other Formulations

Food, Beverages & Nutrition By End Use (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Research Laboratories
  • Military Institutions

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓